GSK plc (GSK) Competitors & Peers
The 5 largest companies in the same industry as GSK plc, by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| LLY | Peer | $1,422.72 | P/E 46.2RSI 68Cap 1.34 T |
| JNJ | Peer | $281.32 | P/E 42.7RSI 62Cap 677.2 B |
| ABBV | Peer | $293.60 | P/E 50.5RSI 60Cap 518.7 B |
| MRK | Peer | $146.53 | P/E 148.0RSI 51Cap 361.9 B |
| AZN | Peer | $186.08 | P/E 26.3RSI 66Cap 289.1 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- AUPHCompetitor
Aurinia's Lupkynis competes with GSK's Benlysta for lupus nephritis treatment market share.
Model-inferred, unverified — treat as a lead, not evidence - IDYAPartner
GSK partners with IDEAYA to co-develop MAT2A inhibitors in oncology programs.
Model-inferred, unverified — treat as a lead, not evidence